Follow the POLYNOVO LIMITED stock price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €666.7m. The latest transaction was filed on 29 June 2026 (Change in Substantial Holding). Among the most active insiders: There was a change in the interests of the. All data is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate POLYNOVO LIMITED Buy (bullish), based on 8 analysts. Average price target: A$1.46.
Fundamental score
Ranked 13,687 of 29,063 companies
53.6
score / 100
Value
43
Quality
64
FCF yld1.3%
Earn yld1.1%
EV/EBITDA·
ROE8.4%
Gross mgn89%
Net mgn5.1%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
POLYNOVO LIMITED is an Australian Securities Exchange listed company focused on developing innovative medical devices. It primarily concentrates on wound care solutions and biomaterial implants.